Oral involvement of chronic graftversus-host disease in hematopoietic stem cell transplant recipients

General Dentistry

Volumn 59, Issue 6, 2011, Pages 458-462

  Noce, Cesar W ^a   Gomes, Alessandra ^a   Copello, Alvaro ^d   Barbosa, Raquel D ^d   Sant'anna, Simone ^c   Moreira, Maria Claudia R ^d   Correa, Maria Elvira P ^b   Maiolino, Angelo ^d   Torres, Sandra R ^d  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ACUTE DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BRAZIL; CHRONIC DISEASE; CHRONIC MYELOID LEUKEMIA; CROSS-SECTIONAL STUDY; FEMALE; GINGIVA DISEASE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; JOINT CHARACTERISTICS AND FUNCTIONS; LEUKOPLAKIA; LICHENOID ERUPTION; MALE; MIDDLE AGED; MOUTH DISEASE; MOUTH ULCER; PAIN ASSESSMENT; PHYSIOLOGY; SALIVA; SECRETION; STATISTICS; TONGUE DISEASE; XEROSTOMIA;

ACUTE DISEASE; ADOLESCENT; ADULT; BRAZIL; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; GINGIVAL DISEASES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, ACUTE; LEUKOPLAKIA, ORAL; LICHENOID ERUPTIONS; MALE; MIDDLE AGED; MOUTH DISEASES; ORAL ULCER; PAIN MEASUREMENT; RANGE OF MOTION, ARTICULAR; SALIVA; SECRETORY RATE; TONGUE DISEASES; XEROSTOMIA; YOUNG ADULT;

EID: 84856472114     PISSN: 03636771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, Martin P, Chien J, Przepiorka D, Couriel D, Cowen EW, Dinndorf P, Farrell A, Hartzman R, Henslee-Downey J, Jacobsohn D, McDonald G, Mittleman B, Rizzo JD, Robinson M, Schubert M, Schultz K, Shulman H, Turner M, Vogelsang G, Flowers ME. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplantation 2005; 11(12):945-956. (Pubitemid 41754712)
2. Boer CC, Correa ME, Miranda EC, de Souza CA. Taste disorders and oral evaluation in patients undergoing allogeneic hematopoietic SCT. Bone Marrow Transplant 2010;45(4):705-711. Epub 2009 Sep 21.
3. Giaccone L, Martin P, Carpenter P, Moravec C, Hooper H, Funke VA, Storb R, Flowers ME. Safety and potential efficacy of low-dose methotrexate for treatment of chronic graftversus- host disease. Bone Marrow Transplant 2005;36(4): 337-341. (Pubitemid 41195167)
4. Pereira CM, de Almeida OP, Correa ME, Souza CA, Barjas-Castro ML. Oral involvement in chronic graft versus host disease: A prospective study of 19 Brazilian patients. Gen Dent 2007; 55(1):48-51.
5. Schubert MM , Correa ME . Oral graft-versushost disease. Dent Clin North Am 2008;52(1): 79-109, viii-ix.
6. Silva MM, Bouzas LF, Filgueira AL. Tegumentary manifestations of graft-versus-host disease in bone marrow transplantation recipients. An Bras Dermatol 2005;80(1):69-80. (Pubitemid 40462686)
7. Busca A, Locatelli F, Marmont F, Ceretto C, Falda M. Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. Am J Hematol 2007;82(1):45-52. (Pubitemid 46033391)
8. Fall-Dickson JM, Mitchell SA, Marden S, Ramsay ES, Guadagnini JP, Wu T, St John L, Pavletic SZ; National Institutes of Health Chronic Graft-versus- Host Disease Study Group. Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease. Biol Blood Marrow Transplantation 2010;16(7):948-756 Epub 2010 Feb 6.
9. Friedrichs B, Tichelli A, Bacigalupo A, Russell NH, Ruutu T, Shapira MY, Beksac M, Hasenclever D, Socie G, Schmitz N. Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: A randomised trial. Lancet Oncol 2010;11(4):331-338 Epub 2010 Jan 30.
10. Wang Y, Xu LP, Liu DH, Chen H, Chen YH, Han W, Liu KY, Huang XJ. First-line therapy for chronic graft-versus-host disease that includes lowdose methotrexate is associated with a high response rate. Biol Blood Marrow Transplantation 2009;15(4):505-511. Epub 2009 Feb 12.
11. Schubert MM, Williams BE, Lloid ME, Donaldson G, Chapko MK. Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index. Cancer 1992;69(10): 2469-2477.
12. de la Rosa Garcia E, Bologna Molina R, Vega Gonzalez Tde J. Graft-versus-host disease, an eight case report and literature review. Med Oral Patol Oral Cir Bucal 2006;11:E486-E492.
13. Resende RG, Correia-Silva Jde F, de Almeida HC, Vaz RR, Gomez RS. Letter to the editor. Mucoceles. Spec Care Dentist 2010;30(3):127-128.
14. Treister NS, Woo SB, O'Holleran EW, Lehmann LE , Parsons SK, Guinan EC. Oral chronic graft-versus-host disease in pediatric patients after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005;11(9): 721-731. (Pubitemid 41194981)
15. Nagler R, Barness-Hadar L, Lieba M, Nagler A. Salivary antioxidant capacity in graft-versus-host disease. Cancer Invest 2006;24(3):269-277.
16. Pavletic SZ, Martin P, Lee SJ, Mitchell S, Jacobsohn D, Cowen EW, Turner ML, Akpek G, Gilman A, McDonald G, Schubert M, Berger A, Bross P, Chien JW, Couriel D, Dunn JP, Fall-Dickson J, Farrell A, Flowers ME, Greinix H, Hirschfeld S, Gerber L, Kim S, Knobler R, Lachenbruch PA , Miller FW, Mittleman B, Papadopoulos E, Parsons SK, Przepiorka D, Robinson M, Ward M, Reeve B, Rider LG, Shulman H, Schultz KR, Weisdorf D, Vogelsang GB; Response Criteria Working Group. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: IV. Response to Criteria Working Group Report. Biol Blood Marrow Transplant 2006;12(3):252-266. (Pubitemid 43273710)
17. American Society for Blood and Marrow Transplantation. Chronic GVHD activity assessment- Clinician. Available at: http://asbmt. affiniscape.com/ associations/11741/files/ ResponseCriteriaAPPENDIXAFormA.pdf. Accessed February 16, 2011.
18. Torres SR, Peixoto CB, Caldas DM, Silva EB, Akiti T, Nucci M, de Uzeda M. Relationship between salivary flow rates and Candida counts in subjects with xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93(2):149-154. (Pubitemid 41115717)
19. Marton K, Madlena M, Banoczy J, Varga G, Fejerdy P, Sreebny LM, Nagy G. Unstimulated whole saliva flow rate in relation to sicca symptoms in Hungary. Oral Dis 2008;14(5):472-477. (Pubitemid 351841724)
20. Dijkstra PU, Huisman PM, Roodenburg JL. Criteria for trismus in head and neck oncology. Int J Oral Maxillofac Surg 2006;35(4):337-342. Epub 2005 Nov 8. (Pubitemid 43286265)
21. Navazesh M, Kumar SK. Xerostomia: Prevalence, diagnosis, and management. Compend Contin Educ Dent 2009;30(6):326-328, 331-322.
22. Dawes C. Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man. J Dent Res 2006;66 Spec No:648-653.
23. Skert C, Patriarca F, Sperotto A, Cerno M, Fili C, Zaja F, Stocchi R, Geromin A, Damiani D, Fanin R. Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: Incidence, predictors and outcome. Haematologica 2006;91(2):258-261.
24. Treister NS, Cook EF Jr, Antin J, Lee SJ, Soiffer R, Woo SB. Clinical evaluation of oral chronic graft-versus-host disease. Biol Blood Marrow Transplant 2008;14(1):110-115. (Pubitemid 350286745)
25. Dijkstra PU, Kalk WW, Roodenburg JL. Trismus in head and neck oncology: A systematic review. Oral Oncol 2004;40(9):879-889. (Pubitemid 39369559)